AUROBINDO PHARMA
Back to Income Statement
|
AUROBINDO PHARMA Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹31,724 Cr | ₹29,002 Cr | ₹24,855 Cr | ₹23,455 Cr | ₹24,775 Cr |
What is the latest Revenue of AUROBINDO PHARMA ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹31,724 Cr |
| Mar2025 | ₹29,002 Cr |
| Mar2024 | ₹24,855 Cr |
| Mar2023 | ₹23,455 Cr |
| Mar2022 | ₹24,775 Cr |
How is Revenue of AUROBINDO PHARMA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹31,724 Cr | 9.39 | |
| Mar2025 | ₹29,002 Cr | 16.68 | |
| Mar2024 | ₹24,855 Cr | 5.97 | |
| Mar2023 | ₹23,455 Cr | -5.32 | |
| Mar2022 | ₹24,775 Cr | - | |
Compare Revenue of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹95,130.9 Cr | -2.2% | 4% | 58.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,634.0 Cr | -2.9% | -2.3% | 21.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,576.0 Cr | -1.6% | 9.8% | 51.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -2.6% | -2.3% | 37.5% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | -2.2% | -6.1% | -12.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,322.1 Cr | -0.9% | -1.8% | -9.8% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | -2.2% |
4% |
58.6% |
| SENSEX | -1% |
-2.6% |
-4.1% |
You may also like the below Video Courses